The Patient in Pain
4. Kishner S. Pain assessment. http://emedicine.medscape.com/article/1948069-overview. Last accessed 13 June 2014. 5.
PHARMACY
Drugs and the Liver/Gastrointestinal System
In liver cirrhosis portosystemic shunting reduces blood flow to the liver. High HER drugs will be less metabolised and have higher bioavailability. Therefore doses should be reduced. For example, oral…
Drug Administration
Fig. 2.1 Schematic diagram showing the various pharmacokinetic processes following administration of a drug. D drug, P protein, R receptor How Pharmacokinetics Influence the Clinical Effect of a Drug Pharmacokinetic…
Pharmaceutical Aspects of Drugs
Drug Development Drug development is defined as the process of bringing a new drug to the market once a compound has been identified as potentially being able to impact a…
Why Drugs Are Administered
In acutely ill patients, many of these parameters will not be known to the provider. An idea of the physiological status of these patients is obtained from their history, physical…
The Pharmaceutical Companies Assessment and Experience with the Centralised Procedure
, Mohammed Al-Rubaie2, Stuart Walker3 and Sam Salek4 (1) Regulatory Affairs Consultant Executive Directive, Kuwait Advancement for Conference and Exhibition Management, Kuwait, Kuwait (2) Ministry of Health, Directorate General of Pharmaceutical Affairs and…
The Centralised Regulatory Review in the Gulf Region
, Mohammed Al-Rubaie2, Stuart Walker3 and Sam Salek4 (1) Regulatory Affairs Consultant Executive Directive, Kuwait Advancement for Conference and Exhibition Management, Kuwait, Kuwait (2) Ministry of Health, Directorate General of Pharmaceutical Affairs and…
The Current Status of Drug Safety and Pharmacovigilance
, Mohammed Al-Rubaie2, Stuart Walker3 and Sam Salek4 (1) Regulatory Affairs Consultant Executive Directive, Kuwait Advancement for Conference and Exhibition Management, Kuwait, Kuwait (2) Ministry of Health, Directorate General of Pharmaceutical Affairs and…
The Gulf States Assessment and Experience with the Centralised Procedure
, Mohammed Al-Rubaie2, Stuart Walker3 and Sam Salek4 (1) Regulatory Affairs Consultant Executive Directive, Kuwait Advancement for Conference and Exhibition Management, Kuwait, Kuwait (2) Ministry of Health, Directorate General of Pharmaceutical Affairs and…
The Strategic Planning Process of the GCC Regulatory Authorities: Barriers and Solutions
, Mohammed Al-Rubaie2, Stuart Walker3 and Sam Salek4 (1) Regulatory Affairs Consultant Executive Directive, Kuwait Advancement for Conference and Exhibition Management, Kuwait, Kuwait (2) Ministry of Health, Directorate General of Pharmaceutical Affairs and…
